Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-25-000058
Filing Date
2025-04-09
Accepted
2025-04-09 17:12:06
Documents
1
Period of Report
2025-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1744233117.html 4  
1 FORM 4 wk-form4_1744233117.xml 4 8846
  Complete submission text file 0001599298-25-000058.txt   10468
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Reporting) CIK: 0001055919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 25825876

Mailing Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131
Business Address 601 BRICKELL KEY DRIVE SUITE 1000 MIAMI FL 33131 305-203-2034
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

EIN.: 371979717 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)